J2305 HCPCS code: Injection, nitroglycerin, 5 mg
J2305 is the HCPCS Level II code for injection, nitroglycerin, 5 mg. In 2024 Medicare paid an average of $1.03 per service for J2305 across 716 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume fell 2% from 2023 to 2024 (729 to 716 services). In 2024, about 52 clinicians billed Medicare for J2305 for 397 beneficiaries; Florida, Texas, Minnesota accounted for 78% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2024-01-01 |
Who bills J2305 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 52 |
| Medicare beneficiaries | 397 |
| States with claims | 8 |
| Share of services in top 3 states (Florida, Texas, Minnesota) | 78% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2305, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 729 | 163 | $1.27 | $1.01 |
| 2024 | 716 | 397 | $1.31 | $1.03 |
States with the most J2305 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 224 | $1.05 |
| Texas | 156 | $1.07 |
| Minnesota | 54 | $1.08 |
| Maryland | 54 | $1.04 |
| Ohio | 21 | $1.08 |
What changed for J2305
- 2023-07-01: J2305 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2305?
J2305 is the HCPCS Level II code for injection, nitroglycerin, 5 mg. Short descriptor: "Inj, nitroglycerin, 5 mg".
How much does Medicare pay for J2305?
In 2024, the average Medicare payment was $1.03 per service (average allowed $1.31).
Does Medicare cover J2305?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J23 codes
- J2300 — Injection, nalbuphine hydrochloride, per 10 mg
- J2310 — Injection, naloxone hydrochloride, per 1 mg
- J2311 — Injection, naloxone hydrochloride (zimhi), 1 mg
- J2312 — Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
- J2313 — Injection, naloxone hydrochloride (zimhi), 0.01 mg
- J2315 — Injection, naltrexone, depot form, 1 mg
- J2320 — Injection, nandrolone decanoate, up to 50 mg
- J2323 — Injection, natalizumab, 1 mg
- J2325 — Injection, nesiritide, 0.1 mg
- J2326 — Injection, nusinersen, 0.1 mg
- J2327 — Injection, risankizumab-rzaa, intravenous, 1 mg
- J2329 — Injection, ublituximab-xiiy, 1mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2305
- Watch J2305 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2305
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.